Showing posts with label mrsa. Show all posts
Showing posts with label mrsa. Show all posts

Wednesday 14 November 2012

DNA sequencing of MRSA


DNA sequencing of MRSA used to stop outbreak

MRSA

Related Stories

An outbreak of the hospital superbug MRSA has been brought to an end by UK doctors cracking the bacterium's genetic code.
It led to them finding one member of staff at Rosie Hospital, in Cambridge, who may have unwittingly carried and spread the infection.
They say it is the first time rapid genetic testing has been used to track and then stop an outbreak.
One expert said this would soon become "standard practice" in hospitals.
Doctors were concerned after MRSA was detected in 12 babies during routing screening.

MRSA

MRSA - or methicillin-resistant staphylococcus aureus - is a bacterial infection that is resistant to a number of widely-used antibiotics.
People can carry the bug without health problems and it is spread by skin-to-skin contact or through contaminated objects such as bedding.
It can cause life-threatening infections if the bug breaches the skin, such as through a surgical wound.
However, current tests could not tell if it was one single outbreak being spread around the unit or if they were separate cases being brought into the hospital. About one in 100 people carry MRSA on their skin without any health problems.
To find out, researchers at the University of Cambridge and the Sanger Institute embarked on more sophisticated version of a paternity test.
They compared the entire genetic code of MRSA bugs from each baby to build a family tree. It showed they were all closely related and part of the same outbreak.
After two months without a case and deep cleaning the ward, another case appeared. Analysing the DNA showed that it was again part of the outbreak and attention turned to a carrier.
Tests on 154 members of staff showed that one was also carrying MRSA, which may have been spread to babies in the unit. They were treated to remove the infection.
"We believe this brought the outbreak to a close," said Dr Julian Parkhill, from the Sanger Institute.
"This is really exciting for us because it gave the hospital the opportunity to intervene.
"We think this is the first case where whole genome sequencing has actually led to a clinical intervention and brought the outbreak to a close."
Bacterial DNABacterial DNA was analysed
The study was published in the medical journal Lancet Infectious Diseases.
Cheaper
The cost of working out the entire genetic code of a bacterium has plummeted from millions of pounds to about £50.
The time it takes has also fallen dramatically from months to hours.
Dr Parkhill said it could get even cheaper: "People are talking about the thousand dollar human genome.
"If you can do the human genome for a thousand dollars you can do a bacterial genome for one dollar."
Commenting on the research Prof Ross Fitzgerald, from the Roslin Institute at the University of Edinburgh, told the BBC: "The study clearly highlights the power of whole genome sequencing for resolving the source and the spread of an epidemic of hospital acquired infection such as MRSA.
"It will ultimately, within a small number of years, be standard practice for any hospital outbreak.
"I fully expect this to be rolled out as a standard approach in UK hospitals in the very near future."
Prof Sharon Peacock, from the University of Cambridge, said she wanted to develop a simple system that could be used easily by hospitals.
She said she envisioned a "black box" where the genetic sequence goes in and a simple report that can be used by hospital staff comes out.
"It could, for example, determine the species of the bacterium; it could determine antibiotic susceptibility, and it could provide information about what genes are present that are often associated with poor outcomes in patients."
Sir Mark Walport, director of the Wellcome Trust, said: "This is a dramatic demonstration that medical genomics is no longer a technology of the future - it is a technology of the here and now."

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

Thursday 30 August 2012

Vitamin B3 'helps kill superbugs'????


Vitamin B3 'helps kill superbugs'


Drug-resistant MRSAAntibiotic resistance is increasing

Related Stories

Vitamin B3 could be the new weapon in the fight against superbugs such as MRSA, researchers have suggested.
US experts found B3, also known as nicotinamide, boosts the ability of immune cells to kill Staphylococcus bacteria.
B3 increases the numbers and efficacy of neutrophils, white blood cells that can kill and eat harmful bugs.
The study, in the Journal of Clinical Investigation, could lead to a "major change in treatment", a UK expert said.
B3 was tested on Staphylococcal infections, such as the potentially fatal MRSA (Methicillin-resistant Staphylococcus aureus).
Such infections are found in hospitals and nursing homes, but are also on the rise in prisons, the military and among athletes.
'Turn on'
The scientists used extremely high doses of B3 - far higher than that obtained from dietary sources - in their tests, carried out both on animals and on human blood.

Start Quote

I cannot see why this couldn't be used straight away in infected patients”
Prof Mark Enright,University of Bath
And the researchers say there is as yet no evidence that dietary B3 or supplements could prevent or treat bacterial infections.
The researchers say B3 appears to be able to "turn on" certain antimicrobial genes, boosting the immune cells' killing power.
Prof Adrian Gombart, of Oregon State University's Linus Pauling Institute, who worked on the research, said: "This is potentially very significant, although we still need to do human studies.
"Antibiotics are wonder drugs, but they face increasing problems with resistance by various types of bacteria, especially Staphylococcus aureus.
"This could give us a new way to treat Staph infections that can be deadly, and might be used in combination with current antibiotics.
"It's a way to tap into the power of the innate immune system and stimulate it to provide a more powerful and natural immune response."
Prof Mark Enright, of the University of Bath, said: "Neutrophils are really the front line against infections in the blood and the use of nicotinamide seems safe at this dose to use in patients as it is already licensed for use.
"This could cause a major change in treatment for infections alongside conventional antibiotics to help bolster patients immune system.
"I would like to see in patient clinical trials but cannot see why this couldn't be used straight away in infected patients."

More on This Story

Related Stories

Vitamin B3 (Niacin)


Vitamin B3 (Niacin)

Overview:

Vitamin
B3 is one of 8 B vitamins. It is also known as niacin (nicotinic acid) and has 2 other forms, niacinamide (nicotinamide) and inositol hexanicotinate, which have different effects from niacin.
All B vitamins help the body to convert food (carbohydrates) into fuel (glucose), which is used to produce energy. These B vitamins, often referred to as B complex vitamins, also help the body use fats and protein. B complex vitamins are needed for healthy skin, hair, eyes, and liver. They also help the nervous system function properly.
Niacin also helps the body make various sex and stress-related hormones in the adrenal glands and other parts of the body. Niacin helps improve circulation.
All the B vitamins are water-soluble, meaning that the body does not store them.
You can meet all of your body's needs for B3 through diet. It is rare for anyone in the developed world to have a B3 deficiency. In the United States, alcoholism is the main cause of vitamin B3 deficiency.
Symptoms of mild deficiency include indigestion, fatigue, canker sores, vomiting, and depression. Severe deficiency can cause a condition known as pellagra. Pellagra is characterized by cracked, scaly skin, dementia, and diarrhea. It is generally treated with a nutritionally balanced diet and niacin supplements. Niacin deficiency also causes burning in the mouth and a swollen, bright red tongue.
Very high doses of B3, available by prescription, have been studied to prevent or improve symptoms of the following conditions. However, at high doses niacin can be toxic. You should not take doses higher than the Recommended Daily Allowance except under your doctor's supervision. Researchers are trying to determine if inositol hexanicotinate has similar benefits without serious side effects, but so far results are preliminary.
High Cholesterol
Niacin -- but not niacinamide -- has been used since the 1950s to try to lower elevated LDL ("bad") cholesterol and triglyceride (fat) levels in the blood. However, side effects can be unpleasant and even dangerous. High doses of niacin cause flushing of the skin, stomach upset (which usually subsides within a few weeks), headache, dizziness, and blurred vision. There is an increased risk of liver damage. A time-release form of niacin reduces flushing, but its long-term use is associated with liver damage. In addition, niacin can interact with other cholesterol-lowering drugs (see "Possible Interactions"). You should not take niacin at high doses without your doctor's supervision.
Atherosclerosis and Heart Disease
In one study, men with existing heart disease slowed down the progression of atherosclerosis by taking niacin along with colestipol. They had fewer heart attacks and deaths, as well.
In another study, people with heart disease and high cholesterol who took niacin along with simvastatin (Zocor) had a lower risk of having a first heart attack or stroke. Their risk of death was also lower. In another study, men who took niacin alone seemed to reduce the risk of having a second heart attack, although it did not reduce the risk of death.
Diabetes
Some evidence suggests that niacinamide (but not niacin) might help delay the time that you would need to take insulin in type 1 diabetes. In type 1 diabetes, the body's immune system mistakenly attacks the cells in the pancreas that make insulin, eventually destroying them. Niacinamide may help protect those cells for a time, but more research is needed to tell for sure.
Researchers have also looked at whether high-dose niacinamide might reduce the risk of type 1 diabetes in children at risk for the disease. One study found that it did, but another, larger study found it did not protect against developing type 1 diabetes. More research is needed to know for sure.
The effect of niacin on type 2 diabetes is more complicated. People with type 2 diabetes often have high levels of fats and cholesterol in the blood. Niacin, often along with other drugs, can lower those levels. However, niacin may also raise blood sugar levels, which is particularly dangerous for someone with diabetes. For that reason, anyone with diabetes should take niacin only when directed to do so by their doctor, and should be carefully monitored for high blood sugar.
Osteoarthritis
One preliminary study suggested that niacinamide may improve arthritis symptoms, including increasing joint mobility and reducing the amount of nonsteroidal anti-inflammatory drugs (NSAIDs) needed. More research is needed.
Other
Alzheimer's disease -- Population studies show that people who get higher levels of niacin in their diet have a lower risk of Alzheimer's disease. No studies have evaluated niacin supplements, however.
Cataracts -- One large population study found that people who got a lot of niacin in their diets had a lower risk of developing cataracts.
Skin conditions -- Researchers are studying topical forms of niacin as treatments for rosacea, aging, and prevention of skin cancer, although it's too early to know whether it is effective.
Researchers are also studying the use of vitamin B3 in treating ADHD, migraines, dizziness, depression, motion sickness, and alcohol dependence. But there is no evidence that it helps treat any of these conditions.

Dietary Sources:

The best food sources of vitamin B3 are found in beets, brewer's yeast, beef liver, beef kidney, fish, salmon, swordfish, tuna, sunflower seeds, and peanuts. Bread and cereals are usually fortified with niacin. In addition, foods that contain tryptophan, an amino acid the body coverts into niacin, include poultry, red meat, eggs, and dairy products.

Available Forms:

Vitamin B3 is available in several different supplement forms: niacinamide, niacin, and inositol hexaniacinate. Niacin is available as a tablet or capsule in both regular and timed-release forms. The timed-release tablets and capsules may have fewer side effects than regular niacin. However, the timed-release versions are more likely to cause liver damage. Regardless of which form of niacin you're using, doctors recommend periodic liver function tests when using high doses (above 100 mg per day) of niacin.

How to Take It:

Daily recommendations for niacin in the diet of healthy individuals are listed below.
Generally, high doses of niacin are used to control specific diseases. Such high doses must be prescribed by a doctor, who will have you increase the amount of niacin slowly, over the course of 4 - 6 weeks, and take the medicine with meals to avoid stomach irritation.
Pediatric
  • Infants birth - 6 months: 2 mg (adequate intake)
  • Infants 7 months - 1 year: 4 mg (adequate intake)
  • Children 1- 3 years: 6 mg (RDA)
  • Children 4 - 8 years: 8 mg (RDA)
  • Children 9 - 13 years: 12 mg (RDA)
  • Boys 14 - 18 years: 16 mg (RDA)
  • Girls 14 - 18 years: 14 mg (RDA)
Adult
  • Men 19 years and older: 16 mg (RDA)
  • Women 19 years and older: 14 mg (RDA)
  • Pregnant women: 18 mg (RDA)
  • Breastfeeding women: 17 mg (RDA)

Precautions:

Because of the potential for side effects and interactions with medications, you should take dietary supplements only under the supervision of a knowledgeable health care provider.
High doses (50 mg or more) of niacin can cause side effects. The most common side effect is called "niacin flush," which is a burning, tingling sensation in the face and chest, and red or flushed skin. Taking an aspirin 30 minutes prior to the niacin may help reduce this symptom.
At the very high doses used to lower cholesterol and treat other conditions, liver damage and stomach ulcers can occur. Your health care provider will regularly check your liver function through a blood test.
People with a history of liver disease, kidney disease, or stomach ulcers should not take niacin supplements. Those with diabetes or gallbladder disease should do so only under the close supervision of their doctor.
Stop taking niacin or niacinamide at least two weeks before a scheduled surgery.
Niacin and niacinamide may make allergies worse by increasing histamine.
People with low blood pressure should not take niacin or niacinamide because they may cause a dangerous drop in blood pressure. Don' t take niacin if you have a history of gout.
People with coronary artery disease or unstable angina should not take niacin without their doctor' s supervision, as large doses can raise the risk of heart rhythm problems.
Taking any one of the B vitamins for a long period of time can result in an imbalance of other important B vitamins. For this reason, you may want to take a B complex vitamin, which includes all the B vitamins.

Possible Interactions:

If you are currently taking any of the following medications, you should not use niacin without first talking to your health care provider.
Antibiotics, Tetracycline -- Niacin should not be taken at the same time as the antibiotic tetracycline because it interferes with the absorption and effectiveness of this medication. All vitamin B complex supplements act in this way and should be taken at different times from tetracycline.
Aspirin -- Taking aspirin before taking niacin may reduce flushing from niacin, but take it only under your doctor's supervision.
Anti-seizure Medications -- Phenytoin (Dilantin) and valproic acid (Depakote) may cause niacin deficiency in some people. Taking niacin with carbamazepine (Tegretol) or mysoline (Primidone) may increase levels of these medications in the body.
Anticoagulants (blood thinners) -- Niacin may make the effects of these medications stronger, increasing the risk of bleeding.
Blood Pressure Medications, Alpha-blockers -- Niacin can make the effects of medications taken to lower blood pressure stronger, leading to the risk of low blood pressure.
Cholesterol-lowering Medications -- Niacin binds the cholesterol lowering medications known as bile-acid sequestrants and may make them less effective. For this reason, niacin and these medications should be taken at different times of the day. Bile-acid sequestrants include colestipol (Colestid), colesevelam (Welchol), and cholestyramine (Questran).
Statins -- Some scientific evidence suggests that taking niacin with simvastatin (Zocor) appears to slow down the progression of heart disease. However, the combination may also increase the likelihood for serious side effects, such as muscle inflammation or liver damage.
Diabetes Medications -- Niacin may increase blood sugar levels. People taking insulin, metformin (Glucophage), glyburide (Dibeta, Micronase), glipizide (Glucotrol), or other medications used to treat high blood glucose levels should monitor their blood sugar levels closely when taking niacin supplements.
Isoniazid (INH) -- INH, a medication used to treat tuberculosis, may cause a niacin deficiency.
Nicotine Patches -- Using nicotine patches with niacin may worsen or increase the risk of flushing associated with niacin.
These medications may lower levels of niacin in the body:
  • Azathioprine (Imuran)
  • Chloramphenicol (Chloromycetin)
  • Cycloserine (Seromycin)
  • Fluorouracil
  • Levodopa and carbidopa
  • Mercaptopurine (Purinethol)

Alternative Names:

Inositol hexaniacinate; Niacin; Niacinamide; Nicotinamide; Nicotinic acid
  • Reviewed last on: 8/31/2011
  • A.D.A.M. Editorial Team: David Zieve, MD, MHA, and David R. Eltz. Previously reviewed by Steven D. Ehrlich, NMD, Solutions Acupuncture, a private practice specializing in complementary and alternative medicine, Phoenix, AZ. Review provided by VeriMed Healthcare Network (6/12/2011).

Supporting Research

AIM-HIGH Investigators. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH). Am Heart J. 2011 Mar;161(3):471-477.e2.
Bissett DL, Oblong JE, Berge CA, et al. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005;31:860-865; discussion 865.
Brown BG, Zhao XQ, Chalt A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345(22):1583-1592.
Cumming RG, Mitchell P, Smith W. Diet and cataract: the Blue Mountains Eye Study. Ophthalmology. 2000;107(3):450-456.
Draelos ZD, Ertel K, Berge C, et al. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005;76:135-141.
Elam M, Hunninghake DB, Davis KB, et al. Effects of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial. Arterial Disease Multiple Intervention Trial. JAMA. 2000;284:1263-1270.
Garcia-Closas R. et al. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer. 2007;43(11):1731-40.
Goldberg A, Alagona P, Capuzzi DM, et al. Multiple-dose efficacy and safety of an extended-release form of niacin in management of hyperlipidemia. Am J Cardiol. 2000;85:1100-1105.
Guyton JR. Niacin in cardiovascular prevention: mechanisms, efficacy, and safety. Curr Opin Lipidol. 2007 Aug;18(4):415-20.
Jacques PF, Chylack LT Jr, Hankinson SE, et al. Long-term nutrient intake and early age related nuclear lens opacities. Arch Ophthalmol. 2001;119(7):1009-1019.
Kuzniarz M, Mitchell P, Cumming RG, Flood VM. Use of vitamin supplements and cataract: the Blue Mountains Eye Study. Am J Ophthalmol. 2001;132(1):19-26.
Mittal MK, Florin T, Perrone J, Delgado JH, Osterhoudt KC. Toxicity from the use of niacin to beat urine drug screening. Ann Emerg Med. 2007;50(5):587-90.
Nutrients and Nutritional Agents. In: Kastrup EK, Hines Burnham T, Short RM, et al, eds. Drug Facts and Comparisons. St. Louis, Mo: Facts and Comparisons; 2000:4-5.
Raja R, Thomas JM, Greenhill-Hopper M, Ley SV, Almeida Paz FA. Facile, one-step production of niacin (vitamin B3) and other nitrogen-containing pharmaceutical chemicals with a single-site heterogeneous catalyst. Chemistry. 2008;14(8):2340-8.
Sanyal S, Karas RH, Kuvin JT. Present-day uses of niacin: effects on lipid and non-lipid parameters. Expert Opin Pharmacother. 2007 Aug;8(11):1711-7.
Torkos S. Drug-nutrient interactions: a focus on cholesterol-lowering agents. Int J Integrative Med. 2000;2(3):9-13.
Wolerton: Comprehensive Dermatalogic Drug Therapy, 2nd ed. Philadelphia, PA: Saunders Elsevier. 2007.
Zhao H, Yang X, Zhou R, Yang Y. Study on vitamin B1, vitamin B2 retention factors in vegetables. Wei Sheng Yan Jiu. 2008;37(1):92-6.


Read more: http://www.umm.edu/altmed/articles/vitamin-b3-000335.htm#ixzz2520UrkZZ

Wednesday 22 August 2012

MRSA and C. diff deaths falling


MRSA and C. diff deaths falling

Deaths from MRSA fell by a quarter, from 485 in 2010 to 364 in 2011.
There were 2,053 C. difficile infections last year, compared with 2,704 the year before.
Earlier this year, the Health Protection Agency warned other infections were taking their place.
Both infections have shown large declines over the past five years after being repeatedly targeted by government policies.
MRSAHowever, there is some concern other infections such as E.coli appear to be rising.
The health minister, Simon Burns, said: "The news that MRSA deaths are lower than at any point in the last 15 years is a testament to the hard work and dedication of NHS staff across the country."

Sunday 6 May 2012

MRSA and C. difficile infections in hospitals fell


Hospital hygiene drive 'saved 10,000 lives'

'CleanYourHands' campaign has led to significant fall in MRSA and other superbug infections, says BMJ report
  • guardian.co.uk, 
  • Article history
A doctor scrubbing up in hospital
MRSA rates in hospitals fell by more than half between July 2004 and June 2008, according to the BMJ study. Photograph: Getty Images
The government-funded campaign to improve hand hygiene at hospitals across England and Wales led to a significant fall in the rates of superbug infections, a report has revealed.
After the "CleanYourHands" campaign was rolled out in 2004, the amount of soap and alcoholic hand rub bought by NHS trusts almost tripled, according to a study published in the British Medical Journal (BMJ).
Over the same period, MRSA rates in hospitals were slashed by more than half, while there was a significant drop in the number of Clostridium difficile infections.
The campaign, backed by the Department of Health, was introduced across the 187 acute NHS trusts in England and Wales between December 2004 and June 2005.
It encouraged hospital visitors, patients and staff to wash their hands with soap or an alcohol gel when entering or leaving wards. People were also encouraged to clean their hands before touching patients or eating food and after going to the toilet.
As part of the drive, alcohol gels were put by bedsides, posters reminded staff to wash their hands and regular checks were made to ensure hands were kept clean.
The BMJ study, which analysed statistics between July 2004 and June 2008, found that the number of patients infected with MRSA fell from 1.88 cases per 10,000 bed days to 0.91 over the four-year period.
Rates of C difficile infection dropped from 16.75 to 9.49 cases, while the number of cases of MSSA – a bacterium found on the skin – did not fall.
The study also found that hospital trust procurement of soap and alcohol hand rub rose from a combined 21.8ml to 59.8ml per patient bed day over the period.
The increased use of soap in hospitals was linked to reduced rates of C difficile infection, while rising use of alcohol hand rub was associated with a reduction in MRSA cases.
The report concludes: "The CleanYourHands campaign was associated with sustained increases in hospital procurement of alcohol rub and soap, which the results suggest has an important role in reducing rates of some healthcare associated infections.
"National interventions for infection control undertaken in the context of a high profile political drive can reduce selected healthcare associated infections."
Sheldon Paul Stone, senior lecturer at UCL medical school, who led the study, estimated that around 10,000 lives were saved because of the campaign, which ended in 2010.
He told the Independent: "Without a doubt, lives were saved by the campaign. I would say 10,000 lives over the four-year period of the study was a reasonable estimate.
"If hand hygiene were a new drug, pharmaceutical companies would be out selling it for all they were worth."
Stone added: "It is obvious the campaign should be continued. Independent groups have suggested it should. It needs a new focus on staff who use gloves. They deal with the most infectious patients but they are much less likely to use soap."
A spokesman from the Department of Health was quoted as saying: "The CleanYourHands campaign was successful in its aim to highlight the importance of good hand hygiene practice across the NHS. We know this has been successful.
"The challenge now is to ensure the NHS embeds the good practice highlighted in the campaign to achieve our ambition to wipe out avoidable healthcare-associated infection."

Hand hygiene campaign 'cut superbug infections'the campaign to improve hand 


hygiene in hospitals in England and Wales contributed to a significant fall in the rates of superbug infections, according to a report.

The study published on the BMJ website showed the amount of soap and hand gel being used tripled during the campaign.
At the same time, levels of MRSA and C. difficile infections in hospitals fell.
The government has since dropped the campaign, but said its ambition was to "wipe out" such infections.
Hospital superbugs were once a real fear for many patients. In response the Clean Your Hands campaign, funded by the Department of Health, was introduced in all hospitals by June 2005.
Alcohol gels were put by bedsides, posters reminded staff to wash their hands and there were regular checks to ensure hands were kept clean.
By 2008, the total amount of soap and alcohol gel being purchased by hospitals trebled, going from 22ml per patient per day to 60ml per patient per day.
Rates of MRSA more than halved in the same time period and C. diff infections fell by more than 40%.
'Success story'
One of the report's authors, Dr Sheldon Stone from the Royal Free University College London Medical School, estimated that around 10,000 lives were saved because of the campaign.
He told the BBC: "It's been a real British success story, we've gone from being the dirty man of Europe to being world leaders.
"What we need to do is keep up the momentum and stay at the forefront of world hand hygiene."
A spokesman from the Department of Health said: "The Clean Your Hands campaign was successful in its aim to highlight the importance of good hand hygiene practice across the NHS. We know this has been successful.
"The challenge now is to ensure the NHS embeds the good practice highlighted in the campaign to achieve our ambition to wipe out avoidable healthcare-associated infection.
"We know real progress has been made in this area as MRSA bloodstream infections have dropped by 41% and C. difficile by 30% across the NHS in England since 2009/10.

Featured post

More patients in Scotland given antidepressants

More patients in Scotland given antidepressants 13 October 2015   From the section Scotland Image copyright Thinkstock Image ca...